China Immunotech (beijing) Biotechnology Co., Ltd.

This early-phase study tested a new cell therapy called YTS109 in 7 people with a severe type of autoimmune hemolytic anemia that did not get better after at least 3 other treatments. The therapy uses specially designed immune cells to attack the faulty cells causing the disease.…